MONTREAL, CANADA--(Marketwire - September 29, 2008) - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that Mr. Sebastien Gignac, ART's Chairman and Chief Executive Officer, will present a company overview at the BioContact investor conference being held at the Fairmount Chateau Frontenac in Quebec City (Canada) from October 1 to 3. Mr. Gignac's presentation will take place on Wednesday, October 1st, 2008, at 3 p.m. (EST) in the Place d'Armes Room.
